NEW YORK — Bristol Myers Squibb Co. today reported fourth-quarter net income of $2.37 billion, after reporting a loss in the same period a year earlier.
On a per-share basis, the company said it had net income of $1.07. Earnings, adjusted for non-recurring costs, came to $1.83 per share.
The results matched Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was also for earnings of $1.83 per share.
The biopharmaceutical company posted revenue of $11.99 billion in the period, beating Street forecasts. Four analysts surveyed by Zacks expected $11.96 billion.
For the year, the company reported net income of $6.99 billion, or $3.12 per share, swinging to a profit in the period. Revenue was reported as $46.39 billion.
Bristol Myers expects full-year earnings in the range of $7.65 to $7.95 per share.
Bristol Myers shares have climbed almost 3% since the beginning of the year, while the S&P’s 500 index has increased 19%. The stock has increased slightly more than 3% in the past 12 months.